Novartis India Q2 Results
- BSE: 500672
- NSE: NOVARTIND
- ISIN: INE234A01025
- Sector: Biotechnology & Drugs
BSE
1,028.2
2.40 (0.23%)
2.40 (0.23%)Volume2.58 K
Updated: Mon 25 Nov, 2024 | 15:29:08
NSE
672.25
0.00 (0.00%)
0.00 (0.00%)Volume0.00
Updated: Wed 25 Oct, 2023 | 15:40:00
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹87.10 Cr.(-5.62%)
- Operating Profit₹17.38 Cr.(-25.79%)
- Profit After Tax₹20.41 Cr.(-20.71%)
- Operating Margin19.95%(-3.35%)
Note: Comparison is on YoY basis
Quarterly - Novartis India Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 87.10 | 90.60 | -% | 78.76 | -% |
| Selling/ General/ Admin Expenses Total | 5.20 | 6.18 | -% | 5.37 | -% |
| Depreciation/ Amortization | 0.58 | 1.56 | -% | 0.65 | -% |
| Other Operating Expenses Total | 14.79 | 14.36 | -% | 11.76 | -% |
| Total Operating Expense | 69.72 | 74.84 | -% | 62.50 | -% |
| Operating Income | 17.38 | 15.76 | -% | 16.26 | -% |
| Net Income Before Taxes | 27.56 | 27.77 | -% | 32.43 | -% |
| Net Income | 20.41 | 20.26 | -% | 23.68 | -% |
| Diluted Normalized EPS | 8.27 | 8.21 | -% | 9.59 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST